Envista Holdings Corporation Common Stock (NVST)

Envista’s latest quarter reflected stable demand in core dental markets but was overshadowed by ongoing macroeconomic uncertainty, particularly in the U.S. a...

Core sales held up, but China destocking and procurement pressure loom ahead.

Envista (NYSE:NVST) reported higher third-quarter sales and adjusted earnings and raised its 2026 profit outlook, as price increases and productivity gains helped offset weaker sales in China. The dental products company reported revenue of $691 million, up 3.2% from a year earlier, while core sale

Dental products company Envista Holdings (NYSE:NVST) met Wall Street’s revenue expectations in Q3 2026, with revenue up 3.2% year on year to $691.5 million. ...

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...

Dental products company Envista Holdings (NYSE:NVST) will be announcing earnings results this Wednesday after market hours. Here’s what you need to know. Env...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the dental equipment & technology industry...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Align Technology (NASDAQ:ALGN...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Over the past six months, Envista’s shares (currently trading at $27.36) have posted a disappointing 7.6% loss, well below the S&P 500’s 10.5% gain. This may...

Margins expanded 230 basis points as core growth accelerated.

Envista’s second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management point...

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Envista (NYSE:NVST) reported second-quarter 2026 sales of $731 million, supported by 5% core revenue growth and contributions from foreign exchange and acquisitions that lifted total revenue growth to just over 7%. President and Chief Executive Officer Paul Keel said the company delivered balanced

Dental products company Envista Holdings (NYSE:NVST) announced better-than-expected revenue in Q2 CY2026, with sales up 7.1% year on year to $730.5 million. ...